Subject: potential for clinical immunogenicity biol. The EpiScreen™ time course T cell proliferation assay was used to determine the potential for clinical immunogenicity of antibody variant H3.It is concluded that the human antibody H3 exhibits a clinically acceptable immunogenicity profile from the EpiScreen™ assay providing confirmation of reduced immunogenicity as a result of the Antitope Composite Human Antibody technology. как перевести "potential for clinical immunogenicity" Спасибо! |
You need to be logged in to post in the forum |